Cefetamet pivoxil

DB18915InvestigationalSmall molecule

Cefetamet pivoxil is under investigation in clinical trial NCT04664803 (Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis).

Formula / weight: C₂₀H₂₅N₅O₇S₂ · 511.57 g/mol (avg)
Also known as: 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))- · Cefatamet pivoxil · Cefetamet pivaloyloxymethyl ester · Cefetamet pivoxyl
Code names: RO 15-8075 · RO 1-9334

Resolves to

Compound

Structure

InChIKeyDASYMCLQENWCJG-XUKDPADISA-NSMILES[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(=O)OCOC(=O)C(C)(C)C

What you can answer from here — as of June 28, 2024

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Cefetamet pivoxil, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.